Microglia, immune cells disguised as brain cells, are known as the janitors of the brain. Dialing up their usual duties just enough could provide an avenue to treat neurodegenerative disease.

A new Alzheimer's drug called lecanemab appears effective in slowing cognitive decline, but may come with some risks.

Alzheimer's disease's debilitating symptoms may be the result of swelling caused by amyloid plaques in the brain, research suggests.

Alzheimer's disease's debilitating symptoms may be the result of swelling caused by amyloid plaques in the brain, research suggests.

Can underproduction of key immune cells contribute to Alzheimer's? A new study suggests the answer is yes.

Common compounds in wine and in green tea reduced the formation of Alzheimer's plaques with few or no side effects.

Only a small number of middle-age adults would be very likely to test new dementia prevention drugs, researchers report.

Cambridge scientists have shown that it may be possible to spot signs of brain impairment in patients as early as nine years before they receive a diagnosis

Free range DNA fragments from a simple blood draw may be signs of higher risk of frailty and dementia, a new study shows.